Overview

The aortic intervention market has consolidated. During 2015, Medtronic acquired Aptus Endosystems for $110 million, Lombard Medical acquired Altura Medical for $23 million and Endologix merged with TriVascular in a $211 million deal. The only innovative company left standing independent in the space is Cardiatis, which is expected to be acquired during 2016 given its disruptive aortic flow diversion technology, its extensive patent portfolio, and the recent Veith symposium presentations highlighting the utility of its technology in repairing difficult to treat thoraco-abdominal aneurysms . According to Medtech Ventures

Full Product Details

9781530324842

Table of Contents

Reviews

Author Information

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available